These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 25376375)

  • 1. Urine drug screening: necessary or alienating?
    Darnall BD; Schatman ME
    Pain Med; 2014 Dec; 15(12):1999. PubMed ID: 25376375
    [No Abstract]   [Full Text] [Related]  

  • 2. Urine drug screening: opioid risks preclude complete patient autonomy.
    Darnall BD; Schatman ME
    Pain Med; 2014 Dec; 15(12):2001-2. PubMed ID: 25376661
    [No Abstract]   [Full Text] [Related]  

  • 3. Few benefits, likely harms: against universal random urine drug screening in pain management.
    Goldberg DS; Rich BA
    Pain Med; 2014 Dec; 15(12):2000-1. PubMed ID: 25376562
    [No Abstract]   [Full Text] [Related]  

  • 4. Trust but verify.
    Compton P
    Pain Med; 2014 Dec; 15(12):1999-2000. PubMed ID: 25376474
    [No Abstract]   [Full Text] [Related]  

  • 5. Why is urine drug testing not used more often in practice?
    Bair MJ; Krebs EE
    Pain Pract; 2010; 10(6):493-6. PubMed ID: 21040440
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: The role of urine drug testing for patients on opioid therapy.
    Collen MR
    Pain Pract; 2011; 11(2):199; author reply 199. PubMed ID: 21371255
    [No Abstract]   [Full Text] [Related]  

  • 7. What is the role of Urine Drug Testing (UDT) in the management of chronic non-cancer pain with opioids?
    Schonwald G
    Pain Med; 2012 Jul; 13(7):853-6. PubMed ID: 22804903
    [No Abstract]   [Full Text] [Related]  

  • 8. [Urine testing in the treatment of opiate addiction].
    Ege PP
    Ugeskr Laeger; 2003 Mar; 165(13):1346-8. PubMed ID: 12703279
    [No Abstract]   [Full Text] [Related]  

  • 9. Opiate DAU screening using dried urine specimens.
    Meany DL; Clarke W
    Clin Chim Acta; 2009 Mar; 401(1-2):188-9. PubMed ID: 19068209
    [No Abstract]   [Full Text] [Related]  

  • 10. Interpretation of urine drug testing in pain patients.
    Pesce A; West C; Egan City K; Strickland J
    Pain Med; 2012 Jul; 13(7):868-85. PubMed ID: 22494459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a polyethylene glycol marker system in urine drug screening in an opiate substitution program.
    Schneider HJ; Rühl B; Meyer K; Keller R; Backmund M
    Eur Addict Res; 2008; 14(4):186-9. PubMed ID: 18583915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of reported drug use and urinalysis in the assessment of drug use.
    Jain R; Tripathi BM; Singh R
    Natl Med J India; 2001; 14(5):315-6. PubMed ID: 11767230
    [No Abstract]   [Full Text] [Related]  

  • 13. Unreliable urine samples.
    Brown S
    Br J Psychiatry; 1989 Jul; 155():130. PubMed ID: 2605426
    [No Abstract]   [Full Text] [Related]  

  • 14. A systematic approach to identifying drug-seeking patients.
    Pretorius RW; Zurick GM
    Fam Pract Manag; 2008 Apr; 15(4):A3-5. PubMed ID: 18444310
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of urine drug testing for patients on opioid therapy.
    Pergolizzi J; Pappagallo M; Stauffer J; Gharibo C; Fortner N; De Jesus MN; Brennan MJ; Richmond C; Hussey D;
    Pain Pract; 2010; 10(6):497-507. PubMed ID: 20412503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False-positive urine opiate screening associated with fluoroquinolone use.
    Zacher JL; Givone DM
    Ann Pharmacother; 2004 Sep; 38(9):1525-8. PubMed ID: 15252190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A leader in the field...
    DeVito RA
    J Opioid Manag; 2015; 11(1):6. PubMed ID: 25881374
    [No Abstract]   [Full Text] [Related]  

  • 19. Retrospective review of physician opioid prescribing practices in patients with aberrant behaviors.
    Gupta A; Patton C; Diskina D; Cheatle M
    Pain Physician; 2011; 14(4):383-9. PubMed ID: 21785482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpreting Urine Drug Screen Results in the Context of Poppy Seed Use.
    Pearson AC; Eldrige JS; Hooten WM
    Mayo Clin Proc; 2015 Dec; 90(12):1734-5. PubMed ID: 26653302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.